Annemarie J M Wijkhuijs
Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors
Hurkmans D, Mathijssen R, Aerts J, van der Veldt A, Schreurs M, van der Leest C, Koch B, Debets R, Jörger M, Wijkhuijs A, Basak E, Putter L, de Joode K, Sassen S, Koolen S. Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors. J Immunother Cancer 2021; 9
Jan 1, 2021Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors
Jan 1, 2021J Immunother Cancer 2021; 9
Hurkmans Daan P, Mathijssen Ron H J, Aerts Joachim G J V, van der Veldt Astrid A M, Schreurs Marco W J, van der Leest Cor H, Koch Birgit C P, Debets Reno, Jörger Markus, Wijkhuijs Annemarie J M, Basak Edwin A, Putter Lisanne, de Joode Karlijn, Sassen Sebastiaan D T, Koolen Stijn L W
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
Hurkmans D, Mathijssen R, Aerts J, van der Leest C, van der Veldt A, Odink A, Jörger M, Debets R, Hoop E, Bins S, Wijkhuijs A, Schreurs M, Mercieca D, van Dijk T, Basak E, Koolen S. A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients. J Immunother Cancer 2019; 7:192.
Jul 19, 2019A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
Jul 19, 2019J Immunother Cancer 2019; 7:192
Hurkmans Daan P, Mathijssen Ron H J, Aerts Joachim G J V, van der Leest Cor H, van der Veldt Astrid A M, Odink Arlette, Jörger Markus, Debets Reno, Hoop Esther Oomen-de, Bins Sander, Wijkhuijs Annemarie J M, Schreurs Marco W J, Mercieca Darlene, van Dijk Tanja, Basak Edwin A, Koolen Stijn L W